FOLLICLE-STIMULATING HORMONE RECEPTOR IS EXPRESSED BY MOST OVARIAN CANCER SUBTYPES AND IS A SAFE AND EFFECTIVE IMMUNOTHERAPEUTIC TARGET

PURPOSE: Define the safety and effectiveness of T-cells re-directed against Follicle-Stimulating Hormone Receptor (FSHR)-expressing ovarian cancer cells. EXPERIMENTAL DESIGN: FSHR expression was determined by Western-blot, immunohistochemistry and Q-PCR in 77 human ovarian cancer specimens from 6 di...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Clin Cancer Res
Main Authors: Perales-Puchalt, Alfredo, Svoronos, Nikolaos, Rutkowski, Melanie R, Allegrezza, Michael J, Tesone, Amelia J, Payne, Kyle K, Wickramasinghe, Jayamanna, Nguyen, Jenny M, O'Brien, Shane W, Gumireddy, Kiranmai, Huang, Qihong, Cadungog, Mark G., Connolly, Denise C, Tchou, Julia, Curiel, Tyler J, Conejo-Garcia, Jose R.
Format: Artigo
Sprog:Inglês
Udgivet: 2016
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5241180/
https://ncbi.nlm.nih.gov/pubmed/27435394
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-16-0492
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker